MALAT1: a potential biomarker in cancer

Area of Science:

• Molecular Biology
• Oncology
• Genomics

Background:

• Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in disease.
• Metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) is a key lncRNA in cancer research.
• MALAT1 is linked to cell signaling, cancer development, progression, and therapy response.

Purpose of the Study:

• To review current knowledge on MALAT1's role in cancer-associated molecular pathways and pathophysiology.
• To explore MALAT1's potential as a biomarker for cancer diagnosis and prognosis.
• To highlight MALAT1 as a potential therapeutic target for human cancers.

Main Methods:

• Comprehensive literature review of studies on MALAT1 in cancer.
• Analysis of MALAT1's involvement in cell proliferation, apoptosis, metastasis, immunity, angiogenesis, and drug resistance.
• Examination of MALAT1's interactions with proteins, RNAs, and DNAs, and its impact on signaling pathways.

Main Results:

• Aberrant MALAT1 expression is associated with cancer pathophysiology.
• MALAT1 regulates key cancer processes through molecular interactions and signaling pathway modulation.
• MALAT1 demonstrates potential for clinical translation in cancer management.

Conclusions:

• MALAT1 lncRNA is a promising biomarker for cancer diagnosis and prognosis.
• MALAT1 may serve as a viable therapeutic target for human cancers.
• Further research into MALAT1 can advance basic understanding and clinical applications.